TeraCyte Analytics
Chamutal Bornstein currently serves as the Director of Biological R&D at TeraCyte Analytics, a position held since September 2024. Previously, Chamutal worked at Immunai as an Associate Principal Scientist from June 2022 to June 2024, and at ADAM Therapeutics as a Research and Development Team Leader from 2019 to 2022. Chamutal's academic career includes roles as a Postdoctoral Researcher, PhD Student, and Research Assistant at the Weizmann Institute of Science from 2011 to 2018, as well as completing an MSc in Molecular Biology at the same institution from 2008 to 2010. Earlier academic experience includes working as a Research Assistant at Bar Ilan University in late 2007 and obtaining a BSc in Biotechnology. Chamutal holds a PhD in Immunology Genomics from the Weizmann Institute of Science.
This person is not in any teams
This person is not in any offices
TeraCyte Analytics
Our breakthrough Array Cytometry (TM) technology introduces large-scale acquisition of dynamic single-cell responses. TeraCyte’s world-renowned team of system biologists, computational biologists and data experts will use this dynamic data to build predictive models and applications and streamline drug development.